Generic Metaglip is sold under the name Glipizide and Metformin tablets, and is available in three different strengths: 2.5 mg/250 mg, 2.5 mg/500 mg, and 5 mg/500 mg. The FDA has assigned an "AB" rating to the drug, meaning that it is equivalent to the brand-name medication. However, generic Metaglip may contain other ingredients, such as fillers and dyes, which may cause problems for people with allergies.
Metaglip was first manufactured by Bristol-Myers Squibb Company. The patent for the drug has since expired, which means a generic Metaglip can now be produced.
Strengths of Generic Metaglip
Generic Metaglip is available in the following strengths:
Glipizide and Metformin 2.5 mg/250 mg tablets -- containing 2.5 mg glipizide and 250 mg metformin
Glipizide and Metformin 2.5 mg/500 mg tablets -- containing 2.5 mg glipizide and 500 mg metformin
Glipizide and Metformin 5 mg/500 mg tablets -- containing 5 mg glipizide and 500 mg metformin.
Who Makes Generic Metaglip?
Generic Metaglip is currently made by two companies: Teva Pharmaceuticals and Corepharma.